New Brain Cancer Treatment Approved By FDA
Links shared publicly online about this topic.
- 348total visits
New Brain Cancer Treatment Approved By FDA
View full resource at huffingtonpost.com
Tags: Brain, Cancer, Brain Cancer, Diet and Nutrition, Drug, FDA
Most Recently Shared on April 21, 2011 at 8:32 pm By:
Stupid brain. Smart brain. http://huff.to/eL5slx #stupidcancer
FDA approves new treatment for most common type of skin cancer
fda.gov — “Today, Erivedge (vismodegib) was approved by the U.S. Food and Drug Administration to treat adult patients with basal cell carcinoma, the most common type of skin cancer. The drug is intended for use in patients with locally advanced basal cell cancer who are not candidates for surgery or radiation and for patients whose cancer has spread to other parts of the body (metastatic).” View full resource at fda.gov
Most Recently Shared on January 30, 2012 at 4:27 pm By:
FDA approves Genentech's Erivedge for basal cell carcinoma.. once daily pill inhibits Hedgehog pathway.. http://t.co/LrK0JbVd #pharma
Picato® Gel Approved - SkinCancer.org
skincancer.org — “Picato® Gel Approved - SkinCancer.org” View full resource at skincancer.org
Most Recently Shared on January 25, 2012 at 10:44 pm By:
SkinCancerFoundation Health Organization and Dermatology
Breaking News: FDA Approves New Treatment for Actinic Keratosis http://t.co/fCZs1NxS
Patient Receives First Prescription For FDA-Approved Brain Tumor Treatment
medicalnewstoday.com — “The University of Illinois Hospital is the first center in North America to prescribe a new FDA-approved treatment for patients with the most common and aggressive type of brain tumor, glioblastom” View full resource at medicalnewstoday.com
Most Recently Shared on December 3, 2011 at 9:05 am By:
MNT Neurology News Neurology and Health News
Patient Receives First Prescription For FDA-Approved Brain Tumor Treatment http://t.co/WaxNi86F #neurology
New Clinical Research Study on Head and Neck Cancer
sanfordhealth.org — “New Clinical Research Study on Head and Neck Cancer” View full resource at sanfordhealth.org
Most Recently Shared on November 8, 2011 at 11:20 pm By:
Sanford Health Healthcare System
Sanford clinical study for oral cancer therapy is now open for enrollment. Learn more http://t.co/hKW4eFCE #clinicaltrial #sanfordresearch
FDA: 35 innovative new drugs approved in fiscal year 2011
fda.gov — “Over the past 12 months, the U.S. Food and Drug Administration approved 35 new medicines. This is among the highest number of approvals in the past decade, surpassed only by 2009 (37). Many of the drugs are important advances for patients, including: two new treatments for hepatitis C; a drug for late-stage prostate cancer; the first new drug for Hodgkin’s lymphoma in 30 years; and the first new drug for lupus in 50 years.” View full resource at fda.gov
Most Recently Shared on November 3, 2011 at 4:08 pm By:
eyeonfda Pharma and Health Lawyer
Press release from #FDA - 35 innovative new drugs approved in fiscal year 2011 http://t.co/lTiE2Z4D
FDA Approves New Indications for Prolia® (Denosumab) for the Treatment of Bone Loss in Patients With Prostate or Breast Cancer Undergoing Hormone Ablation Therapy - MarketWatch
marketwatch.com — “FDA Approves New Indications for Prolia® (Denosumab) for the Treatment of Bone Loss in Patients With Prostate or Breast Cancer Undergoing Hormone Ablation Therapy - MarketWatch” View full resource at marketwatch.com
Most Recently Shared on September 20, 2011 at 1:05 am By:
JanCerny, MD, PhD Hematologist, Physician, Doctor, PhD, Internist, and Oncologist
FDA Approves New Indications for Denosumab to Treat Bone Loss in Pts With Prostate or Breast CA on Hormonal Therapy http://ow.ly/6yY3i
FDA Approves New Indications for Prolia (denosumab) for the Treatment of Bone Loss in Patients With Prostate or Breast Cancer Undergoing Hormone Ablation Therapy
drugs.com — “Prolia (denosumab) is used in the treatment of bone loss in patients with prostate or breast cancer undergoing hormone ablation therapy. Includes Prolia side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on September 20, 2011 at 1:04 am By:
Drugs and Devices OW OW Health
FDA Approves New Indications for Prolia (denosumab) for the Treatment of Bone Loss in Patients With Prosta... http://t.co/vescEIgy #drug
FDA Approves New Indications for Prolia (denosumab) for the Treatment of Bone Loss in Patients With Prostate or Breast Cancer Undergoing Hormone Ablation Therapy
drugs.com — “Prolia (denosumab) is used in the treatment of bone loss in patients with prostate or breast cancer undergoing hormone ablation therapy. Includes Prolia side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on September 20, 2011 at 12:39 am By:
FDA Approves New Indications for Prolia (denosumab) for Cancer Treatment-Induced Bone Loss - http://t.co/f77E3osL
FDA clears Amgen bone drug for cancer patients | Reuters
reuters.com — “WASHINGTON (Reuters) - U.S. drug regulators approved two new uses for Amgen Inc's osteoporosis drug Prolia, allowing it to be used for bone loss associated with certain cancer treatments.The Food and” View full resource at reuters.com
Most Recently Shared on September 19, 2011 at 7:37 pm By:
Hisham Rana, MD Physician and Doctor
News: U.S. FDA clears Amgen bone drug for cancer patients http://t.co/MR0ALdM9 - #health #pharma
New Drug Approved For Treatment Of Non Small Cell Lung Cancer In Specific Patient Population
medicalnewstoday.com — “Lung Cancer Alliance (LCA) applauds the Food and Drug Administration (FDA) approval of Xalkori (crizotinib) with non-small cell lung cancer (NSCLC) who are ALK positive. The drug was approved bas” View full resource at medicalnewstoday.com
Most Recently Shared on September 6, 2011 at 8:05 am By:
New Drug Approved For Treatment Of Non Small Cell Lung Cancer In Specific Patient Population http://mnt.to/3Zrw #lungcancer
FDA Approves New Drug for Advanced NSCLC - QualityPoint Technologies
qualitypointtech.net — “The FDA has approved crizotinib, a novel agent that targets ALK, for the treatment of late-stage non-small cell lung cancer. Medscape Medical News” View full resource at qualitypointtech.net
Most Recently Shared on August 27, 2011 at 12:45 am By:
FDA Approves New Drug for Advanced NSCLC: The FDA has approved crizotinib, a novel agent that targets ALK, for the... http://t.co/fC9lypO
Seattle Genetics prices Adcetris above $100K - FiercePharma
fiercepharma.com — “Yet another $100,000-plus cancer treatment will soon hit the market. Seattle Genetics, which won early FDA approval for its new lymphoma drug Adcetris, has tagged it with a $13,500-per-dose price, Read more...” View full resource at fiercepharma.com
Most Recently Shared on August 22, 2011 at 8:45 pm By:
Is $100K-plus too much to ask for a new approach to fighting Hodgkin's disease? Seattle Genetics thinks not. http://t.co/JXF83hi $SEGN
Melanoma Treatment Made More Possible with New Drug | ThirdAge
thirdage.com — “Melanoma is the most deadly form of skin cancer and it can be difficult to treat. The FDA approved a new drug, Zelboraf, this week that treats the most advanced stages of melanoma.” View full resource at thirdage.com
Most Recently Shared on August 20, 2011 at 6:04 pm By:
Melanoma Treatment Made More Possible with New Drug http://t.co/nkjCmIp
Genentech’s novel melanoma treatment wins FDA OK (Morning Read)
medcitynews.com — “Current medical news from today, including Genentech's new melanoma treatment gets FDA approval, dogs that sniff cancer, and translating the Affordable Care Act” View full resource at medcitynews.com
Most Recently Shared on August 18, 2011 at 1:02 pm By:
Genentech’s novel melanoma treatment wins FDA OK (Morning Read) http://t.co/eArHl3K
FDA approves Zelboraf (vemurafenib) for advanced skin cancer
news-medical.net — “A new drug was approved for advanced skin cancer this Wednesday by U.S. regulators, offering the first new treatment for melanoma in 13 years.” View full resource at news-medical.net
Most Recently Shared on August 18, 2011 at 12:18 pm By:
News-Medical.Net Oncology and Health News
Oncology News: FDA approves Zelboraf (vemurafenib) for advanced skin cancer: A new drug was approved for advance... http://t.co/W7VAXGz
Advertisement
